QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jorden, V. S. Articles by Hutchens, M. P Search for Related Content PubMed PubMed Citation Articles by Jorden, V. S. Articles by Hutchens, M. P

Dexmedetomidine Overdose in the Perioperative Setting

Associate Medical Director, Abbott Laboratories, Inc., Abbott Park, IL; Clinical Assistant Professor, Department of Anesthesiology, The Chicago Medical School, Chicago, IL

Robert M Pousman, DO

Assistant Professor of Anesthesiology, Division of Critical Care and Perioperative Medicine, Vanderbilt University, Nashville, TN

Mary M Sanford, ARNP MSN ACNP

Nurse Practitioner for Critical Care, Catholic Medical Center, Manchester, NH

Per AJ Thorborg, MD PhD

Associate Professor, Department of Anesthesiology and Perioperative Medicine, Oregon Health Sciences University, Portland, OR

Michael P Hutchens, MD MA

Chief Resident, Department of Anesthesiology and Perioperative Medicine, Oregon Health Sciences University

Reprints: Victor SB Jorden MD MPH, Department R440, Abbott Laboratories, 200 Abbott Park Dr., Abbott Park, IL 60046-6229, fax 847/935-7633, victor.jorden{at}abbott.com

OBJECTIVE: To report 3 cases of accidental dexmedetomidine overdose in the perioperative setting and review the pathophysiology of ₂-agonist overdose.

CASE SUMMARIES: Three patients accidentally received overdoses of dexmedetomidine, one intraoperatively (192 µg over 20 min) and 2 postoperatively (4 and 2 rather than 0.4 and 0.2 µg/kg/h; 0.5 µg/kg/min rather than 0.5 µg/kg/h). Hemodynamic parameters remained stable for all 3 patients. The most notable sign was oversedation diagnosed either clinically or using a bispectral index monitor; Naranjo criteria suggest possible or probable association of the reactions with dexmedetomidine. In all 3 cases, oversedation resolved within one hour of drug discontinuation. There were no other sequelae, and the remainder of each patient's hospital course was unremarkable.

DISCUSSION: As of this writing, dexmedetomidine dosing in excess of the label recommendation has been reported, but accidental dexmedetomidine overdose in clinical practice has not been described. Excessive levels of sedation were the only significant finding in all 3 patients. Dexmedetomidine's short redistribution half-life of 6 minutes should lead to rapid resolution of oversedation induced by overdoses if the overall duration of infusion is short (8 h). While the patients reported here were hemodynamically stable, dexmedetomidine may engender significant hemodynamic changes either because of sympatholysis at normal doses or vasoconstriction at higher than recommended doses. The absence of a significant hypertensive response to high dexmedetomidine concentrations suggests that dexmedetomidine-induced hypertension may be multifactorial, not simply related to plasma drug concentrations.

CONCLUSIONS: Practitioners presented with dexmedetomidine overdose should be prepared to manage oversedation. While hemodynamic alterations may be seen with dexmedetomidine use, hypertension from high dexmedetomidine plasma concentrations is not a consistent response. Practitioners using dexmedetomidine should carefully note that dosing for this agent is described by the manufacturer in µg/kg/h, not µg/kg/min.

Key Words: dexmedetomidine, overdose

Published Online, March 23, 2004. www.theannals.com, DOI 10.1345/aph.1D376

This article has been cited by other articles:

				A. T Gerlach and J. F Dasta Dexmedetomidine: An Updated Review Ann. Pharmacother., February 1, 2007; 41(2): 245 - 252. [Abstract] [Full Text] [PDF]